NasdaqCM:NATR

Stock Analysis Report

Nature's Sunshine Products

Executive Summary

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.


Similar Companies

Share Price & News

How has Nature's Sunshine Products's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.9%

NATR

-3.4%

US Personal Products

0.4%

US Market


1 Year Return

12.2%

NATR

23.5%

US Personal Products

6.9%

US Market

Return vs Industry: NATR underperformed the US Personal Products industry which returned 23.5% over the past year.

Return vs Market: NATR exceeded the US Market which returned 6.9% over the past year.


Shareholder returns

NATRIndustryMarket
7 Day0.9%-3.4%0.4%
30 Day-4.8%-2.7%-1.2%
90 Day2.8%-2.8%-0.4%
1 Year12.2%12.2%25.4%23.5%9.3%6.9%
3 Year-35.4%-36.5%40.6%33.4%45.8%36.4%
5 Year-26.2%-32.3%78.1%60.1%62.9%45.1%

Price Volatility Vs. Market

How volatile is Nature's Sunshine Products's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nature's Sunshine Products undervalued compared to its fair value and its price relative to the market?

59.16x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: NATR ($9.31) is trading above our estimate of fair value ($0.36)

Significantly Undervalued: NATR is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: NATR is poor value based on its PE Ratio (59.2x) compared to the Personal Products industry average (17.9x).

PE vs Market: NATR is poor value based on its PE Ratio (59.2x) compared to the US market (17.6x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate NATR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NATR is good value based on its PB Ratio (1.4x) compared to the US Personal Products industry average (3.7x).


Next Steps

Future Growth

How is Nature's Sunshine Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

26.3%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nature's Sunshine Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Nature's Sunshine Products performed over the past 5 years?

-61.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: NATR's earnings have declined by -61% per year over the past 5 years.

Accelerating Growth: NATR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: NATR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (21.4%).


Return on Equity

High ROE: NATR's Return on Equity (2.3%) is considered low.


Return on Assets

ROA vs Industry: NATR's Return on Assets is below or equal to the Personal Products industry average last year.


Return on Capital Employed

ROCE Improving: NATR's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Nature's Sunshine Products's financial position?


Financial Position Analysis

Short Term Liabilities: NATR's short term assets ($105.6M) exceeds its short term liabilities ($63.6M)

Long Term Liabilities: NATR's short term assets (105.6M) exceeds its long term liabilities (27.9M)


Debt to Equity History and Analysis

Debt Level: NATR's debt to equity ratio (1.3%) is considered satisfactory

Reducing Debt: NATR's debt to equity ratio has reduced from 8.8% to 1.3% over the past 5 years.

Debt Coverage: NATR's debt is well covered by operating cash flow (709.9%).

Interest Coverage: NATR's interest payments on its debt are well covered by EBIT (33.2x coverage).


Balance Sheet

Inventory Level: NATR has a high level of physical assets or inventory.

Debt Coverage by Assets: NATR's debt is covered by short term assets (assets are 66.617660x debt).


Next Steps

Dividend

What is Nature's Sunshine Products's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%1.4%markettop25%3.7%industryaverage1.5%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate NATR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate NATR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if NATR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NATR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: NATR is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NATR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Nature's Sunshine Products's salary, the management and board of directors tenure and is there insider trading?

1.8yrs

Average management tenure


CEO

Terrence Moorehead (56yo)

1yrs

Tenure

US$2,996,234

Compensation

Mr. Terrence O. Moorehead has been Chief Executive Officer of Nature's Sunshine Products, Inc since October 1, 2018. He serves as President of Nature's Sunshine Products, Inc. He has been a Director at Nat ...


CEO Compensation Analysis

Compensation vs. Market: Terrence has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Terrence's compensation with company performance.


Management Age and Tenure

1.8yrs

Average Tenure

54.5yo

Average Age

Experienced Management: NATR's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Age and Tenure

5.0yrs

Average Tenure

58yo

Average Age

Experienced Board: NATR's board of directors are considered experienced (5 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$91018 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares100
Max PriceUS$9.10
BuyUS$98,85514 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares10,933
Max PriceUS$9.09
BuyUS$403,51005 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares42,893
Max PriceUS$9.50
BuyUS$1,23503 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares130
Max PriceUS$9.54
BuyUS$95,05230 May 19
Wynnefield Capital, Inc.
EntityCompany
Shares10,000
Max PriceUS$9.55
BuyUS$15,38221 May 19
Wynnefield Capital, Inc.
EntityCompany
Shares1,586
Max PriceUS$9.79
SellUS$26,52007 May 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$8.84
SellUS$28,23005 Apr 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.41
BuyUS$17,38518 Mar 19
Wynnefield Capital, Inc.
EntityCompany
Shares1,666
Max PriceUS$10.44
BuyUS$44,54513 Mar 19
Wynnefield Capital, Inc.
EntityCompany
Shares4,681
Max PriceUS$9.52
SellUS$23,79007 Mar 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$7.93
SellUS$23,88008 Feb 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$7.96
SellUS$23,16003 Jan 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$7.72
BuyUS$22,23513 Dec 18
Wynnefield Capital, Inc.
EntityCompany
Shares2,516
Max PriceUS$8.85
BuyUS$34,19710 Dec 18
Wynnefield Capital, Inc.
EntityCompany
Shares3,902
Max PriceUS$8.80
SellUS$27,03007 Dec 18
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.01
SellUS$27,69006 Dec 18
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.23
BuyUS$3,19528 Nov 18
Wynnefield Capital, Inc.
EntityCompany
Shares359
Max PriceUS$8.90
BuyUS$23,28614 Nov 18
Wynnefield Capital, Inc.
EntityCompany
Shares2,644
Max PriceUS$8.81

Ownership Breakdown


Management Team

  • Joe Baty (62yo)

    CFO & Executive VP of Finance

    • Tenure: 3yrs
    • Compensation: US$993.29k
  • Terrence Moorehead (56yo)

    President

    • Tenure: 1yrs
    • Compensation: US$3.00m
  • Bryant Yates (46yo)

    Executive VP & President of Europe

    • Tenure: 0yrs
    • Compensation: US$463.38k
  • Lynda Hammons (64yo)

    Senior Vice President of Global Quality & Regulatory Affairs

    • Tenure: 0yrs
  • Richard Zhang

    Managing Director of China

    • Tenure: 4.9yrs
  • Henry Zhou

    Managing Director of China for Synergy

    • Tenure: 4.9yrs
  • Eddie Silcock

    Executive VP & President of North America

    • Tenure: 0.5yrs
  • Nathan Brower (39yo)

    Executive VP

    • Tenure: 1.8yrs
  • Tracee Comstock (53yo)

    Vice President of Human Resources

    • Tenure: 1.8yrs
  • Trent McCausland

    Executive Director

    • Tenure: 0yrs

Board Members

  • Kristine Hughes (80yo)

    Chairperson Emeritus

    • Tenure: 0.8yrs
    • Compensation: US$125.75k
  • Rick Moss (61yo)

    Independent Director

    • Tenure: 1.4yrs
    • Compensation: US$123.61k
  • Mary Springer (55yo)

    Independent Director

    • Tenure: 6.1yrs
    • Compensation: US$130.27k
  • Jeff Watkins (58yo)

    Independent Director

    • Tenure: 10.3yrs
    • Compensation: US$123.25k
  • Rob Straus (49yo)

    Independent Director

    • Tenure: 2.3yrs
    • Compensation: US$117.83k
  • Terrence Moorehead (56yo)

    President

    • Tenure: 1yrs
    • Compensation: US$3.00m
  • Bob Mercer (67yo)

    Independent Director

    • Tenure: 9.2yrs
    • Compensation: US$125.75k
  • Sang Geon Kim

    Member of Medical & Scientific Advisory Board

    • Tenure: 5.1yrs
  • Ingrum Bankston

    Member of Medical & Scientific Advisory Board

    • Tenure: 5yrs
  • Trent McCausland

    Executive Director

    • Tenure: 0yrs

Company Information

Nature's Sunshine Products, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nature's Sunshine Products, Inc.
  • Ticker: NATR
  • Exchange: NasdaqCM
  • Founded: 1972
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$179.704m
  • Shares outstanding: 19.30m
  • Website: https://www.naturessunshine.com

Number of Employees


Location

  • Nature's Sunshine Products, Inc.
  • 2901 West Bluegrass boulevard
  • Suite 100
  • Lehi
  • Utah
  • 84043
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NATRNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJun 1979

Biography

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 23:38
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.